More Bang For The Buck Needed In Pediatric Cardiac Device Development
This article was originally published in The Gray Sheet
Despite recent attention to the matter by Congress, further incentives are needed to induce development of pediatric devices, physicians say
You may also be interested in...
Developing medical technologies exclusively for children has not typically been an easy or profitable path to tread
FDA action awaits Sun’s manufacturing facility in Halol after it failed to adequately address GMP deviations, though India’s top-ranked drug firm appears to have effectively lowered its dependence on the site that has had a patchy compliance run.
In a surprise to the market, Dr Reddy’s and Hikma have prevailed in challenging six method-of-use patents shielding Amarin’s Vascepa in the US, opening the door for a potential at-risk launch that would likely be challenged by the originator.